BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10891543)

  • 1. Overproduction of IL-8 results in suppression of bone metastasis by lung cancer cells in vivo.
    Iguchi H; Ono M; Matsushima K; Kuwano M
    Int J Oncol; 2000 Aug; 17(2):329-33. PubMed ID: 10891543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis.
    Iguchi H; Tanaka S; Ozawa Y; Kashiwakuma T; Kimura T; Hiraga T; Ozawa H; Kono A
    Cancer Res; 1996 Sep; 56(17):4040-3. PubMed ID: 8752176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice.
    Iwasaki T; Yamashita K; Tsujimura T; Kashiwamura S; Tsutsui H; Kaisho T; Sugihara A; Yamada N; Mukai M; Yoneda T; Okamura H; Akedo H; Terada N
    J Immunother; 2002; 25 Suppl 1():S52-60. PubMed ID: 12048351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
    Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
    Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
    Yoneda T; Sasaki A; Dunstan C; Williams PJ; Bauss F; De Clerck YA; Mundy GR
    J Clin Invest; 1997 May; 99(10):2509-17. PubMed ID: 9153295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.
    Yamaji H; Iizasa T; Koh E; Suzuki M; Otsuji M; Chang H; Motohashi S; Yokoi S; Hiroshima K; Tagawa M; Nakayama T; Fujisawa T
    Cancer Immunol Immunother; 2004 Sep; 53(9):786-92. PubMed ID: 15185009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
    Luca M; Huang S; Gershenwald JE; Singh RK; Reich R; Bar-Eli M
    Am J Pathol; 1997 Oct; 151(4):1105-13. PubMed ID: 9327744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
    Inoue K; Karashima T; Fukata S; Nomura A; Kawada C; Kurabayashi A; Furihata M; Ohtsuki Y; Shuin T
    Clin Cancer Res; 2005 Sep; 11(18):6669-77. PubMed ID: 16166446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of CXCL14 in osteolytic bone metastasis from lung cancer.
    Takiguchi S; Korenaga N; Inoue K; Sugi E; Kataoka Y; Matsusue K; Futagami K; Li YJ; Kukita T; Teramoto N; Iguchi H
    Int J Oncol; 2014 Apr; 44(4):1316-24. PubMed ID: 24534874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of CD24 suppresses bone metastasis of lung cancer.
    Okabe H; Aoki K; Yogosawa S; Saito M; Marumo K; Yoshida K
    Cancer Sci; 2018 Jan; 109(1):112-120. PubMed ID: 29095550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis.
    Tomita A; Kasaoka T; Inui T; Toyoshima M; Nishiyama H; Saiki H; Iguchi H; Nakajima M
    Clin Exp Metastasis; 2008; 25(4):437-44. PubMed ID: 18301992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
    Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis.
    Seike T; Fujita K; Yamakawa Y; Kido MA; Takiguchi S; Teramoto N; Iguchi H; Noda M
    Clin Exp Metastasis; 2011 Jan; 28(1):13-25. PubMed ID: 20953899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen.
    Iguchi H; Onuma E; Sato K; Sato K; Ogata E
    Int J Cancer; 2001 Oct; 94(1):24-7. PubMed ID: 11668474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
    Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
    Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
    Boucharaba A; Serre CM; Grès S; Saulnier-Blache JS; Bordet JC; Guglielmi J; Clézardin P; Peyruchaud O
    J Clin Invest; 2004 Dec; 114(12):1714-25. PubMed ID: 15599396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivo.
    Liu H; Wang Z; Li Y; Li W; Chen Y
    Neoplasma; 2013; 60(3):240-6. PubMed ID: 23373992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system].
    Sheng L; Wu CY; Chen XF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 May; 31(5):684-9. PubMed ID: 21812275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
    Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.